[1]
|
Vogelmeier, C.F., Criner, G.J., Martínez, F.J., et al. (2017) Global Strategy for the Diagnosis, Management, and Preven-tion of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Archivos de Bronconeumología, 53,128-149. https://doi.org/10.1016/j.arbr.2017.02.001
|
[2]
|
Barreiro, E., Bustamante, V., Curull, V., et al. (2016) Relationships between Chronic Obstructive Pulmonary Disease and Lung Cancer: Biological Insights. Journal of Tho-racic Disease, 8, E1122-E1135.
https://doi.org/10.21037/jtd.2016.09.54
|
[3]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[4]
|
Salvato, I., Ricciardi, L., Nucera, F., et al. (2023) RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer. COPD: Journal of Chronic Obstructive Pulmonary Disease, 20, 18-30.
https://doi.org/10.1080/15412555.2022.2107500
|
[5]
|
尚立芝, 季书, 李耀洋, 等. 二陈汤加味对急性加重期COPD患者CXCL8及CXCR1/2蛋白表达的影响[J]. 中国实验方剂学杂志, 2019, 25(24): 1-8.
|
[6]
|
李黎, 张文琪, 李强, 等. LASP1和HIF-1α在肺癌中的表达及临床价值[J]. 广东医学, 2020, 41(24): 2569-2573.
|
[7]
|
Ponce-Gallegos, M., Ramírez-Venegas, A. and Falfán-Valencia, R. (2017) Th17 Profile in COPD Ex-acerbations. International Journal of Chronic Obstructive Pulmonary Disease, 12, 1857-1865.
https://doi.org/10.2147/COPD.S136592
|
[8]
|
Paplińska-Goryca, M., Nejman-Gryz, P., Górska, K., et al. (2018) Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD. In: Pokorski, M., Ed., Clinical Research Involving Pulmonary Disorders, Springer, Cham, 101-112. https://doi.org/10.1007/5584_2016_165
|
[9]
|
李大治, 王春娥, 陈志斌, 等. 应用基因表达谱芯片分析初步探讨全真一气汤抑制COPD大鼠肺损伤的作用机制[J]. 中医临床研究, 2018, 10(35): 5-9.
|
[10]
|
Shi, J., Guo, J. and Li, X. (2018) Role of LASP-1, a Novel SOX9 Transcriptional Target, in the Progression of Lung Cancer. International Journal of Oncology, 52, 179-188. https://doi.org/10.3892/ijo.2017.4201
|
[11]
|
王春娥, 陈志斌, 陈可强, 等. 全真一气汤对肾不纳气证慢性阻塞性肺疾病稳定期患者肺功能、运动耐量及MMP-9的影响[J]. 广西中医药, 2017, 40(1): 14-16.
|
[12]
|
张晶, 严桂珍. 全真一气汤治疗肾气虚型支气管哮喘缓解期32例疗效观察[J]. 福建中医药, 2016, 47(3): 40-42.
|
[13]
|
张晶, 李大治, 严桂珍. 全真一气汤颗粒剂治疗肾不纳气证COPD稳定期患者临床疗效观察[J]. 亚太传统医药, 2014, 10(24): 91-92.
|
[14]
|
木亚莎尔∙吐逊江, 王雨琳, 曹洪丽. 慢性阻塞性肺疾病合并肺癌共同发病机制[J]. 中国组织化学与细胞化学杂志, 2022, 31(4): 412-416.
|
[15]
|
韩勇, 徐晖, 王安辉, 等. 慢性阻塞性肺疾病是肺癌的危险因素[J]. 第四军医大学学报, 2005, 26(2): 146-149.
|
[16]
|
Lowry, K.P., Gazelle, G.S., Gil-more, M.E., et al. (2015) Personalizing Annual Lung Cancer Screening for Patients with Chronic Obstructive Pulmonary Disease: A Decision Analysis. Cancer, 121, 1556-1562.
https://doi.org/10.1002/cncr.29225
|
[17]
|
Kaur, M. and Singh, D. (2013) Neutrophil Chemotaxis Caused by Chronic Obstructive Pulmonary Disease Alveolar Macrophages: The Role of CXCL8 and the Receptors CXCR1/CXCR2. Jour-nal of Pharmacology and Experimental Therapeutics, 347, 173-180. https://doi.org/10.1124/jpet.112.201855
|
[18]
|
Belchamber, K. and Donnelly, L.E. (2017) Macrophage Dysfunction in Respiratory Disease. In: Kloc, M., Ed., Macrophages, Springer, Cham, 299-313. https://doi.org/10.1007/978-3-319-54090-0_12
|
[19]
|
Vacchini, A., Mortier, A., Proost, P., et al. (2018) Differential Effects of Posttranslational Modifications of CXCL8/Inter- leukin-8 on CXCR1 and CXCR2 Internalization and Signal-ing Properties. International Journal of Molecular Sciences, 19, Article 3768. https://doi.org/10.3390/ijms19123768
|
[20]
|
Long, X.X., Ye, Y.N., Zhang, L.J., et al. (2016) IL-8, a Novel Mes-senger to Cross-Link Inflammation and Tumor EMT via Autocrine and Paracrine Pathways (Review). International Journal of Oncology, 48, 5-12.
https://doi.org/10.3892/ijo.2015.3234
|
[21]
|
Brat, D.J., Bellail, A.C. and Van Meir, E.G. (2005) The Role of Inter-leukin-8 and Its Receptors in Gliomagenesis and Tumoral Angiogenesis. Neuro-Oncology, 7, 122-133. https://doi.org/10.1215/S1152851704001061
|
[22]
|
Veenstra, M. and Ransohoff, R.M. (2012) Chemokine Receptor CXCR2: Physiology Regulator and Neuroinflammation Controller? Journal of Neuroimmunology, 246, 1-9. https://doi.org/10.1016/j.jneuroim.2012.02.016
|
[23]
|
尚立芝, 季书, 石龙涛, 等. 基于CXCL8-CXCR1/2轴探讨二陈汤加味对COPD大鼠的抗炎机制[J]. 中国实验方剂学杂志, 2020, 26(11): 40-48.
|
[24]
|
McColl, S.R., Kreis, C., DiPersio, J.F., Borgeat, P. and Naccache, P.H. (1989) Involvement of Guanine Nucleotide Binding Proteins in Neutro-phil Activation and Priming by GM-CSF. Blood, 73, 588-591.
https://doi.org/10.1182/blood.V73.2.588.588
|
[25]
|
Sozzani, S., Agwu, D.E., Ellenburg, M.D., et al. (1994) Activa-tion of Phospholipase D by Interleukin-8 in Human Neutrophils. Blood, 84, 3895-3901. https://doi.org/10.1182/blood.V84.11.3895.bloodjournal84113895
|
[26]
|
Park, C.R., You, D.J., Park, S., et al. (2016) The Accessory Proteins REEP5 and REEP6 Refine CXCR1-Mediated Cellular Responses and Lung Cancer Pro-gression. Scientific Reports, 6, Article No. 39041.
https://doi.org/10.1038/srep39041
|
[27]
|
Tomasetto, C., Moog-Lutz, C., Régnier, C.H., et al. (1995) Lasp-1 (MLN 50) Defines a New LIM Protein Subfamily Characterized by the Association of LIM and SH3 Domains. FEBS Letters, 373, 245-249.
https://doi.org/10.1016/0014-5793(95)01040-L
|
[28]
|
Gao, Q., Tang, L., Wu, L., et al. (2018) LASP1 Promotes Nasopharyngeal Carcinoma Progression through Negatively Regulation of the Tumor Suppressor PTEN. Cell Death & Disease, 9, Article No. 393.
https://doi.org/10.1038/s41419-018-0443-y
|
[29]
|
Niu, Y., Shao, Z., Wang, H., et al. (2016) LASP1-S100A11 Axis Promotes Colorectal Cancer Aggressiveness by Modulating TGFβ/Smad Signaling. Scientific Reports, 6, Article No. 26112. https://doi.org/10.1038/srep26112
|
[30]
|
Zhang, X., Liu, Y., Fan, C., et al. (2017) Lasp1 Promotes Malignant Phenotype of Non-Small-Cell Lung Cancer via Inducing Phosphorylation of FAK-AKT Pathway. Oncotarget, 8, 75102-75113.
https://doi.org/10.18632/oncotarget.20527
|
[31]
|
Xue, Q., Jiang, H., Wang, J. and Wei, D.S. (2021) LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-β1/Smad/Snail Pathway. Canadian Respiratory Journal, 2021, Article ID: 5277409.
https://doi.org/10.1155/2021/5277409
|
[32]
|
Raman, D., Sai, J., Neel, N.F., Chew, C.S. and Richmond, A. (2010) LIM and SH3 Protein-1 Modulates CXCR2-Me- diated Cell Migration. PLOS ONE, 5, e10050. https://doi.org/10.1371/journal.pone.0010050
|
[33]
|
赵晓婷, 孙洁, 刘爽, 等. 三阴乳腺癌中CXCR1和CXCR2的表达及临床意义[J]. 中国医科大学学报, 2017, 46(7): 636-639.
|
[34]
|
范学亮, 郑鹤, 徐海元, 等. 免疫组化法测定LASP1蛋白在鼻咽癌组织中的表达及影响因素分析[J]. 临床研究, 2020, 28(9): 12-13.
|
[35]
|
Mantovani, A., Al-lavena, P., Sica, A. and Balkwill, F. (2008) Cancer-Related Inflammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[36]
|
Lievense, L.A., Bezemer, K., Aerts, J.G. and Hegmans, J.P.J.J. (2013) Tumor-Associated Macrophages in Thoracic Malignancies. Lung Cancer, 80, 256-262. https://doi.org/10.1016/j.lungcan.2013.02.017
|
[37]
|
李丽杰, 宫晓燕, 王爽. 宫晓燕辨治孤立性肺结节病机思路[J]. 吉林中医药, 2021, 41(3): 359-362.
|
[38]
|
郑淑君, 王辛秋, 贾喜花, 等. 国医大师晁恩祥辨治肺癌经验[J]. 中华中医药杂志, 2022, 37(7): 3855-3857.
|
[39]
|
杨丽, 郭栴子, 杨小蒨, 等. 从“痰瘀互结”理论谈“炎—癌转化”[J]. 河北中医, 2020, 42(12): 1887-1889.
|
[40]
|
夏学传. 全真一气汤探析[J]. 安徽中医学院学报, 1999(5): 21-22.
|
[41]
|
迟宇昊, 李暘, 申远. 麦冬化学成分及药理作用研究进展[J]. 新乡医学院学报, 2021, 38(2): 189-192.
|
[42]
|
魏海涛, 方秋华, 张炳顺, 等. 白术有效成分及药理作用研究进展[J]. 广东畜牧兽医科技, 2022, 47(6): 40-44, 51.
|
[43]
|
陈金鹏, 张克霞, 刘毅, 等. 地黄化学成分和药理作用的研究进展[J]. 中草药, 2021, 52(6): 1772-1784.
|
[44]
|
申劲锋, 赵俊. 牛膝多糖的药理研究进展[J]. 天津药学, 2006, 18(1): 59-61.
|
[45]
|
边才苗, 杨云斌, 费杰, 等. 五味子提取物体外抑菌作用初探[J]. 浙江中医药大学学报, 2009, 33(1): 122-123.
|
[46]
|
荣宝山, 黄凯丽, 袁琳嫣, 等. 乌头类药材化学成分和药理作用研究进展[J]. 中国药事, 2021, 35(8): 932-947.
|
[47]
|
孟丽娟, 王学廷, 田敏, 等. 茎叶人参皂甙对肺损伤的保护[J]. 中国临床康复, 2005, 9(15): 136-137.
|